Citadel Advisors’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.8M Sell
281,501
-13,415
-5% -$85.6K ﹤0.01% 2777
2025
Q1
$1.43M Buy
294,916
+144,090
+96% +$700K ﹤0.01% 2899
2024
Q4
$1.44M Buy
150,826
+130,338
+636% +$1.25M ﹤0.01% 2936
2024
Q3
$171K Sell
20,488
-325,866
-94% -$2.72M ﹤0.01% 4716
2024
Q2
$2.36M Buy
346,354
+263,284
+317% +$1.8M ﹤0.01% 2289
2024
Q1
$210K Buy
83,070
+8,176
+11% +$20.7K ﹤0.01% 4741
2023
Q4
$180K Sell
74,894
-1,125,649
-94% -$2.7M ﹤0.01% 4652
2023
Q3
$4.08M Buy
1,200,543
+579,140
+93% +$1.97M ﹤0.01% 1790
2023
Q2
$4.57M Buy
621,403
+183,944
+42% +$1.35M ﹤0.01% 1776
2023
Q1
$4.53M Buy
437,459
+244,353
+127% +$2.53M ﹤0.01% 1898
2022
Q4
$2.28M Sell
193,106
-383,378
-67% -$4.53M ﹤0.01% 2455
2022
Q3
$12.1M Buy
576,484
+417,773
+263% +$8.77M ﹤0.01% 1128
2022
Q2
$4.93M Buy
158,711
+20,937
+15% +$650K ﹤0.01% 1873
2022
Q1
$5.66M Buy
137,774
+83,303
+153% +$3.42M ﹤0.01% 1962
2021
Q4
$2.37M Sell
54,471
-178,007
-77% -$7.74M ﹤0.01% 2871
2021
Q3
$11.6M Buy
232,478
+90,716
+64% +$4.54M ﹤0.01% 1309
2021
Q2
$8.93M Buy
141,762
+40,671
+40% +$2.56M ﹤0.01% 1536
2021
Q1
$9.39M Buy
101,091
+11,116
+12% +$1.03M ﹤0.01% 1480
2020
Q4
$8.06M Buy
89,975
+45,734
+103% +$4.1M ﹤0.01% 1406
2020
Q3
$4.57M Buy
44,241
+41,395
+1,454% +$4.28M ﹤0.01% 1580
2020
Q2
$225K Sell
2,846
-132,129
-98% -$10.4M ﹤0.01% 3999
2020
Q1
$7.81M Sell
134,975
-13,015
-9% -$753K ﹤0.01% 1154
2019
Q4
$7.98M Buy
147,990
+98,727
+200% +$5.33M ﹤0.01% 1313
2019
Q3
$2.58M Sell
49,263
-41,686
-46% -$2.18M ﹤0.01% 2171
2019
Q2
$4.39M Sell
90,949
-12,858
-12% -$621K ﹤0.01% 1763
2019
Q1
$5.25M Buy
103,807
+60,292
+139% +$3.05M ﹤0.01% 1554
2018
Q4
$2.58M Sell
43,515
-45,367
-51% -$2.69M ﹤0.01% 1997
2018
Q3
$5.85M Buy
88,882
+53,849
+154% +$3.54M ﹤0.01% 1427
2018
Q2
$1.77M Buy
35,033
+18,969
+118% +$958K ﹤0.01% 2244
2018
Q1
$846K Buy
16,064
+5,338
+50% +$281K ﹤0.01% 2578
2017
Q4
$498K Sell
10,726
-6,251
-37% -$290K ﹤0.01% 2813
2017
Q3
$687K Sell
16,977
-120,747
-88% -$4.89M ﹤0.01% 2518
2017
Q2
$4.67M Buy
137,724
+28,963
+27% +$982K ﹤0.01% 1226
2017
Q1
$3.16M Buy
108,761
+32,906
+43% +$956K ﹤0.01% 1414
2016
Q4
$2.49M Buy
75,855
+11,473
+18% +$377K ﹤0.01% 1389
2016
Q3
$2.03M Buy
64,382
+49,493
+332% +$1.56M ﹤0.01% 1549
2016
Q2
$419K Sell
14,889
-120,927
-89% -$3.4M ﹤0.01% 2348
2016
Q1
$4.94M Buy
135,816
+132,467
+3,955% +$4.82M 0.01% 1012
2015
Q4
$134K Sell
3,349
-15,263
-82% -$611K ﹤0.01% 3139
2015
Q3
$530K Buy
18,612
+941
+5% +$26.8K ﹤0.01% 2576
2015
Q2
$583K Sell
17,671
-107,557
-86% -$3.55M ﹤0.01% 2458
2015
Q1
$3.6M Buy
125,228
+56,312
+82% +$1.62M ﹤0.01% 1450
2014
Q4
$1.88M Sell
68,916
-56,312
-45% -$1.53M ﹤0.01% 1707
2014
Q3
$2.67M Buy
125,228
+113,848
+1,000% +$2.43M ﹤0.01% 1440
2014
Q2
$256K Sell
11,380
-84,282
-88% -$1.9M ﹤0.01% 2690
2014
Q1
$2.42M Buy
95,662
+46,836
+96% +$1.18M ﹤0.01% 1380
2013
Q4
$1.12M Sell
48,826
-6,274
-11% -$144K ﹤0.01% 1619
2013
Q3
$1.05M Sell
55,100
-39,109
-42% -$745K ﹤0.01% 1566
2013
Q2
$1.36M Buy
+94,209
New +$1.36M ﹤0.01% 1560